Skip to main content
logo
Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.640
+0.040 (1.54%)
At close: Aug 11, 2026, 4:00 PM EDT
2.650
+0.010 (0.38%)
After-hours: Aug 11, 2026, 4:26 PM EDT

Cellectar Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-20.84-21.79-44.58-42.77-31.79-24.12
Depreciation & Amortization
0.050.210.290.190.150.15
Stock-Based Compensation
1.592.264.272.411.451.12
Other Adjustments
-1.12-0.68-5.844.323.290.08
Changes in Accounts Payable
0.85-3.16-1.593.71.620.41
Changes in Other Operating Activities
0.10.03-0.13-0.220.06-0.21
Operating Cash Flow
-18.58-23.12-47.58-32.38-25.22-22.57
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.01-0.1-0.86-0.23-0.14
Investing Cash Flow
-0.01-0.01-0.1-0.86-0.23-0.14

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
-13.0361.4122.949.611.25
Net Common Stock Issued (Repurchased)
-13.0361.4122.949.611.25
Financing Cash Flow
-13.0361.4122.949.611.25

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-5.56-10.0913.72-10.3-15.84-21.46

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-18.59-23.12-47.69-33.24-25.45-22.71
Free Cash Flow Growth
------
Free Cash Flow Per Share
-5.67-8.87-38.52-81.60-108.20-122.72
Levered Free Cash Flow
-19.85-24.71-46.12-39.97-30.19-23.92
Unlevered Free Cash Flow
-21.38-25.9-53.24-36.21-27.26-23.92
SEC Filings: 10-K · 10-Q